Skip to main content
. 2020 Apr 24;4(6):825–833. doi: 10.1002/hep4.1511

Table 1.

Characteristics of Patients with Cirrhosis (n = 129)

Variables Total (Mean, SD) OR (n, %) No Surveillance (n = 26) Surveillance (n = 79) P Value
Age, in years 65.9 (9.88) 68.2 (5.98) 65.2 (11.6) 0.29
Male gender 125 (96.9%) 24 (92.3%) 77 (97.5%) 0.22
Race/Ethnicity 0.23
Non‐Hispanic white 51 (39.5%) 12 (46.2%) 30 (38.0%)
Non‐Hispanic black 19 (14.7%) 2 (7.7%) 13 (16.5%)
Hispanic or Latino 39 (30.2%) 5 (19.2%) 27 (34.2%)
Asian 2 (1.6%) 1 (3.9%) 0 (0%)
Other/Unknown 18 (14.0%) 6 (23.1%) 9 (11.4%)
Etiology of Cirrhosis 0.72
Hepatitis C 83 (64.3%) 17 (65.4%) 53 (67.1%)
ALD 26 (20.1%) 4 (15.4%) 15 (19.0%)
Nonalcoholic Steatohepatitis 13 (10.1%) 2 (11.5%) 6 (7.6%)
Other/Unknown 7 (6.0%) 2 (7.7%) 5 (6.3%)
Decompensated Cirrhosis and Complications 41 (31.8%) 9 (34.6%) 27 (34.2%) 0.47
Ascites 35 (27%) 9 (34.6%) 22 (27.9%) 0.82
Hepatic encephalopathy 16 (12.4%) 7 (26.9%) 8 (10.1%) 0.33
Variceal hemorrhage 18 (14.0%) 2 (7.7%) 14 (17.7%) 0.12
Number of PCP visits in the previous year 2.1 (1.7) 2.1 (1.9) 2.3 (1.8) 0.28
Number of GI/hepatology visits in the previous year 0.53 (1.1) 0.73 (1.46) 0.57 (1.02) 0.57
Successfully reached by patient navigator 42 (32.5%) 5 (19.2%) 29 (36.7%) 0.21
Distance from the VAGLAHS, in miles 45.6 (45.9) 41.6 (44.1) 43.0 (44.7) 0.42

“Surveillance” is defined as abdominal imaging with AFP or abdominal imaging alone. “No surveillance” is defined as neither abdominal imaging nor serum AFP within the follow‐up period.